All blog posts
Total 216 results for
Showing 108 out of 216 results
03 December 2020
Clinical trials in the post-Brexit world
03 December 2020
Comparator products in the post-Brexit world
03 December 2020
Biological products in the post-Brexit world
26 November 2020
The European Commission considers the future of health in Europe with new Pharmaceutical Strategy and Action Plan on IP
20 November 2020
Marketing Authorisations in the post-Brexit world
17 November 2020
Patent and Pharma Update, November 2020
16 November 2020
Approach to assessing entitlement to priority unchanged – TBA in the CRISPR case confirms
13 November 2020
IP in a time of crisis – What does the pharmaceutical sector have to do with a low carbon future?
11 November 2020
Consultation on MHRA draft guidance on the licensing of biosimilar products post transition – open until 15 November 2020
23 September 2020
The Italian medicines agency AIFA opens a public consultation on the draft guidelines for the preparation of the dossier supporting a price and reimbursement application
17 September 2020
Glaxo’s purple inhalers fail to get trade mark protection
11 September 2020
The Unified Patent Court - on the move again?
Showing 108 out of 216 results
View more